Delirium following cardiac procedures—whether surgery or less invasive interventions—carries risks that extend far beyond temporary confusion, according to a modern international review. The condition, characterized by a sudden onset of acute confusion, disorientation, and altered perception, is frequently underestimated in cardiology, yet is linked to longer hospital stays, increased mortality, and a significantly elevated risk of long-term cognitive impairment. This is particularly concerning for older patients, who are most vulnerable.
The review, involving leading cardiologists, surgeons, intensive care physicians, and psychiatrists, underscores that delirium isn’t simply a temporary side effect. It can independently predict long-term mental decline, even in individuals who previously had normal cognitive function. Understanding and addressing delirium in cardiovascular medicine is therefore becoming increasingly critical as populations age and more people undergo cardiac interventions.
The Scope of the Problem and Why It’s Often Missed
The incidence of delirium varies depending on the specific procedure and how it’s measured, but a substantial number of patients are affected. Complex cardiac surgery and interventional procedures like transcatheter aortic valve replacement (TAVR) or percutaneous coronary intervention (PCI) carry inherent risks, especially for elderly patients and those with pre-existing conditions. Experts emphasize that delirium is not a minor complication, but a central challenge in modern cardiac care.
A significant hurdle in addressing delirium is that it often goes unrecognized. The “hypoactive” form, marked by apathy, reduced activity, and listlessness, is particularly prone to being misdiagnosed as age-related decline or simple exhaustion. “Validated and standardized screening instruments such as the Confusion Assessment Method, or CAM for short, with the corresponding extension for intensive care units, which can be used quickly and reliably, are still far too rarely used routinely in everyday clinical practice,” says Endrit Cekaj, an assistant physician at the Clinic for Cardiology at the University Hospital of Bonn (UKB).
Prevention: A Multifaceted Approach
The review highlights prevention as the most effective strategy against delirium. A multimodal approach—incorporating early mobilization, reorientation, sleep hygiene, cognitive stimulation, adequate pain management, and family involvement—can reduce the incidence of delirium by up to 40 percent. However, the authors caution against the routine prophylactic utilize of medication, suggesting a focus on non-pharmacological interventions first.
Dr. David H.V. Vogel, head of the “Experimental Psychopathology” research group at the Clinic for Psychiatry and Psychotherapy at UKB, emphasizes that delirium doesn’t have to be accepted as inevitable. “We also clearly show that delirium does not have to be accepted as inevitable, even if it occurs despite consistent prevention.”
Evidence-Based Treatment Strategies
When delirium does occur, a structured, step-by-step approach is crucial. Non-pharmacological measures remain the foundation of treatment, regardless of severity. Pharmacological options, such as the sedative dexmedetomidine in intensive care settings, can be considered for moderate to severe cases. Antipsychotic substances may be used depending on the specific symptoms, but their potential cardiac side effects must be carefully weighed.
Prof. Dr. Dr. Enzo Lüsebrink, a cardiologist in Bonn, explains, “Our work shows that there are also evidence-based and clinically practicable treatment strategies in the cardiovascular setting—provided that delirium is detected early and treated in an interdisciplinary manner.” Prof. Dr. Alexandra Philipsen, Director of the Clinic for Psychiatry and Psychotherapy at UKB, adds that a holistic view is essential: “We can successfully treat our patients medically for heart conditions. But if we do not systematically recognize and prevent delirium, we risk long-term damage to the brains of those affected. Delirium prevention must therefore grow an integral part of cardiovascular care.”
The Require for Further Research
Despite growing awareness, evidence specifically tailored to cardiovascular patient groups remains limited. The authors of the review call for targeted, prospective studies to develop specific guidelines for both prevention, and treatment. This research is vital to refine strategies and improve outcomes for patients undergoing cardiac procedures.
As the population ages and the number of cardiac interventions continues to rise, recognizing and addressing delirium will become increasingly crucial. The authors’ call for further research underscores the need for a continued commitment to understanding and mitigating the long-term consequences of this often-overlooked complication. The European Heart Journal published the findings in February 2026, prompting a renewed focus on cognitive health within cardiovascular care.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on the importance of delirium screening after cardiac procedures? Share your comments below, and please share this article with anyone who might find it helpful.
